In Brief: NutraMax
This article was originally published in The Tan Sheet
Executive Summary
NutraMax: Forms special committee of its board to "explore strategic alternatives" for the company after MEDIQ announced in November that it may sell its 47% share of the private-labeler, NutraMax said June 19. The committee has hired Wasserstein Perella & Co. as financial advisors. Separately, NutraMax released expected earnings for the third quarter (ending June 30) of $.10-.11 per share, down from $.14 per share last year, due to "continued softness" in cough/cold sales from the mild winter. A backlog of customer cough/cold orders and new eye care product sales should help fuel a recovery in the fourth quarter, the firm said. Early sales of NutraMax's newest line, NutraMax Plus High Calorie Liquid Nutrition, are "very positive," the firm noted; three additional items are slated to be introduced in early fall...